Alphatec Holdings, Inc. (ATEC)
NASDAQ: ATEC · IEX Real-Time Price · USD
11.09
+0.03 (0.27%)
At close: Jul 19, 2024, 4:30 PM
11.10
+0.01 (0.09%)
Pre-market: Jul 20, 2024, 9:29 AM EDT

Alphatec Holdings Revenue

Alphatec Holdings had revenue of $511.63M in the twelve months ending March 31, 2024, with 31.51% growth year-over-year. Revenue in the quarter ending March 31, 2024 was $138.48M with 26.92% year-over-year growth. In the year 2023, Alphatec Holdings had annual revenue of $482.26M with 37.45% growth.

Revenue (ttm)
$511.63M
Revenue Growth
+31.51%
P/S Ratio
3.03
Revenue / Employee
$609,808
Employees
839
Market Cap
1.55B USD

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2023482.26M131.40M37.45%
Dec 31, 2022350.87M107.66M44.26%
Dec 31, 2021243.21M98.35M67.89%
Dec 31, 2020144.86M31.43M27.71%
Dec 31, 2019113.43M21.73M23.70%
Dec 31, 201891.69M-10.05M-9.87%
Dec 31, 2017101.74M-18.51M-15.39%
Dec 31, 2016120.25M-14.14M-10.52%
Dec 31, 2015134.39M-20.24M-13.09%
Dec 31, 2014154.63M-50.10M-24.47%
Dec 31, 2013204.72M8.45M4.30%
Dec 31, 2012196.28M-1.43M-0.72%
Dec 31, 2011197.71M26.10M15.21%
Dec 31, 2010171.61M50.99M42.28%
Dec 31, 2009120.62M28.44M30.85%
Dec 31, 200892.18M12.15M15.18%
Dec 31, 200780.03M6.03M8.14%
Dec 31, 200674.01M--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Teladoc Health 2.62B
Supernus Pharmaceuticals 597.40M
InMode 466.26M
Kiniksa Pharmaceuticals 301.77M
MannKind 224.60M
Schrödinger 188.48M
Avadel Pharmaceuticals 55.14M
Spyre Therapeutics 688.00K
Revenue Rankings